AtriCure (ATRC) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $30.18 +7.29%
Revenue Growth %: +11.7%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +11.7%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $136.1 million versus the consensus estimate of $130.17 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.39)-($0.34), versus the consensus of ($0.51). AtriCure sees FY2025 revenue of $527-533 million, versus the consensus of $523 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
- Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY)
- Deutsche Bank Downgrades Synaptics (SYNA) to Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
